254 related articles for article (PubMed ID: 35955449)
1. A Preclinical Study on Brugada Syndrome with a CACNB2 Variant Using Human Cardiomyocytes from Induced Pluripotent Stem Cells.
Zhong R; Schimanski T; Zhang F; Lan H; Hohn A; Xu Q; Huang M; Liao Z; Qiao L; Yang Z; Li Y; Zhao Z; Li X; Rose L; Albers S; Maywald L; Müller J; Dinkel H; Saguner A; Janssen JWG; Swamy N; Xi Y; Lang S; Kleinsorge M; Duru F; Zhou X; Diecke S; Cyganek L; Akin I; El-Battrawy I
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955449
[TBL] [Abstract][Full Text] [Related]
2. A cellular model of Brugada syndrome with SCN10A variants using human-induced pluripotent stem cell-derived cardiomyocytes.
El-Battrawy I; Albers S; Cyganek L; Zhao Z; Lan H; Li X; Xu Q; Kleinsorge M; Huang M; Liao Z; Zhong R; Rudic B; Müller J; Dinkel H; Lang S; Diecke S; Zimmermann WH; Utikal J; Wieland T; Borggrefe M; Zhou X; Akin I
Europace; 2019 Sep; 21(9):1410-1421. PubMed ID: 31106349
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic mechanism of L-type calcium channel β-subunit downregulation in short QT human induced pluripotent stem cell-derived cardiomyocytes with CACNB2 mutation.
Zhong R; Zhang F; Yang Z; Li Y; Xu Q; Lan H; Cyganek L; El-Battrawy I; Zhou X; Akin I; Borggrefe M
Europace; 2022 Dec; 24(12):2028-2036. PubMed ID: 35894107
[TBL] [Abstract][Full Text] [Related]
4. Novel insights in the pathomechanism of Brugada syndrome and fever-related type 1 ECG changes in a preclinical study using human-induced pluripotent stem cell-derived cardiomyocytes.
Li Y; Dinkel H; Pakalniskyte D; Busley AV; Cyganek L; Zhong R; Zhang F; Xu Q; Maywald L; Aweimer A; Huang M; Liao Z; Meng Z; Yan C; Prädel T; Rose L; Moscu-Gregor A; Hohn A; Yang Z; Qiao L; Mügge A; Zhou X; Akin I; El-Battrawy I
Clin Transl Med; 2023 Mar; 13(3):e1130. PubMed ID: 36881552
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the CACNA1C-R518C Missense Mutation in the Pathobiology of Long-QT Syndrome Using Human Induced Pluripotent Stem Cell Cardiomyocytes Shows Action Potential Prolongation and L-Type Calcium Channel Perturbation.
Estes SI; Ye D; Zhou W; Dotzler SM; Tester DJ; Bos JM; Kim CSJ; Ackerman MJ
Circ Genom Precis Med; 2019 Aug; 12(8):e002534. PubMed ID: 31430211
[TBL] [Abstract][Full Text] [Related]
6. Patient-Specific and Genome-Edited Induced Pluripotent Stem Cell-Derived Cardiomyocytes Elucidate Single-Cell Phenotype of Brugada Syndrome.
Liang P; Sallam K; Wu H; Li Y; Itzhaki I; Garg P; Zhang Y; Vermglinchan V; Lan F; Gu M; Gong T; Zhuge Y; He C; Ebert AD; Sanchez-Freire V; Churko J; Hu S; Sharma A; Lam CK; Scheinman MM; Bers DM; Wu JC
J Am Coll Cardiol; 2016 Nov; 68(19):2086-2096. PubMed ID: 27810048
[TBL] [Abstract][Full Text] [Related]
7. hiPSC-derived cardiomyocytes from Brugada Syndrome patients without identified mutations do not exhibit clear cellular electrophysiological abnormalities.
Veerman CC; Mengarelli I; Guan K; Stauske M; Barc J; Tan HL; Wilde AA; Verkerk AO; Bezzina CR
Sci Rep; 2016 Aug; 6():30967. PubMed ID: 27485484
[TBL] [Abstract][Full Text] [Related]
8. Comparing human iPSC-cardiomyocytes versus HEK293T cells unveils disease-causing effects of Brugada mutation A735V of Na
de la Roche J; Angsutararux P; Kempf H; Janan M; Bolesani E; Thiemann S; Wojciechowski D; Coffee M; Franke A; Schwanke K; Leffler A; Luanpitpong S; Issaragrisil S; Fischer M; Zweigerdt R
Sci Rep; 2019 Aug; 9(1):11173. PubMed ID: 31371804
[TBL] [Abstract][Full Text] [Related]
9. Patient-specific iPSC-derived cardiomyocytes reveal variable phenotypic severity of Brugada syndrome.
Sun Y; Su J; Wang X; Wang J; Guo F; Qiu H; Fan H; Cai D; Wang H; Lin M; Wang W; Feng Y; Fu G; Gong T; Liang P; Jiang C
EBioMedicine; 2023 Sep; 95():104741. PubMed ID: 37544203
[TBL] [Abstract][Full Text] [Related]
10. Studying Brugada Syndrome With an SCN1B Variants in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
El-Battrawy I; Müller J; Zhao Z; Cyganek L; Zhong R; Zhang F; Kleinsorge M; Lan H; Li X; Xu Q; Huang M; Liao Z; Moscu-Gregor A; Albers S; Dinkel H; Lang S; Diecke S; Zimmermann WH; Utikal J; Wieland T; Borggrefe M; Zhou X; Akin I
Front Cell Dev Biol; 2019; 7():261. PubMed ID: 31737628
[TBL] [Abstract][Full Text] [Related]
11. Modeling Short QT Syndrome Using Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
El-Battrawy I; Lan H; Cyganek L; Zhao Z; Li X; Buljubasic F; Lang S; Yücel G; Sattler K; Zimmermann WH; Utikal J; Wieland T; Ravens U; Borggrefe M; Zhou XB; Akin I
J Am Heart Assoc; 2018 Mar; 7(7):. PubMed ID: 29574456
[TBL] [Abstract][Full Text] [Related]
12. Maturation of hiPSC-derived cardiomyocytes promotes adult alternative splicing of SCN5A and reveals changes in sodium current associated with cardiac arrhythmia.
Campostrini G; Kosmidis G; Ward-van Oostwaard D; Davis RP; Yiangou L; Ottaviani D; Veerman CC; Mei H; Orlova VV; Wilde AAM; Bezzina CR; Verkerk AO; Mummery CL; Bellin M
Cardiovasc Res; 2023 Mar; 119(1):167-182. PubMed ID: 35394010
[TBL] [Abstract][Full Text] [Related]
13. HiPSC-derived cardiomyocyte to model Brugada syndrome: both asymptomatic and symptomatic mutation carriers reveal increased arrhythmogenicity.
Penttinen K; Prajapati C; Shah D; Rajan DK; Cherian RM; Swan H; Aalto-Setälä K
BMC Cardiovasc Disord; 2023 Apr; 23(1):208. PubMed ID: 37098502
[TBL] [Abstract][Full Text] [Related]
14. Patient-specific iPSC-derived cardiomyocytes reveal aberrant activation of Wnt/β-catenin signaling in SCN5A-related Brugada syndrome.
Cai D; Wang X; Sun Y; Fan H; Zhou J; Yang Z; Qiu H; Wang J; Su J; Gong T; Jiang C; Liang P
Stem Cell Res Ther; 2023 Sep; 14(1):241. PubMed ID: 37679791
[TBL] [Abstract][Full Text] [Related]
15. Loss of sodium current caused by a Brugada syndrome-associated variant is determined by patient-specific genetic background.
Martínez-Moreno R; Carreras D; Sarquella-Brugada G; Pérez GJ; Selga E; Scornik FS; Brugada R
Heart Rhythm; 2024 Mar; 21(3):331-339. PubMed ID: 38008367
[TBL] [Abstract][Full Text] [Related]
16. Disrupted Ca
Kashiwa A; Makiyama T; Kohjitani H; Maurissen TL; Ishikawa T; Yamamoto Y; Wuriyanghai Y; Gao J; Huang H; Imamura T; Aizawa T; Nishikawa M; Chonabayashi K; Mishima H; Ohno S; Toyoda F; Sato S; Yoshiura KI; Takahashi K; Yoshida Y; Woltjen K; Horie M; Makita N; Kimura T
Heart Rhythm; 2023 Jan; 20(1):89-99. PubMed ID: 36007726
[TBL] [Abstract][Full Text] [Related]
17. Ajmaline blocks I
Miller DC; Harmer SC; Poliandri A; Nobles M; Edwards EC; Ware JS; Sharp TV; McKay TR; Dunkel L; Lambiase PD; Tinker A
Stem Cell Res; 2017 Dec; 25():233-244. PubMed ID: 29172153
[TBL] [Abstract][Full Text] [Related]
18. Modeling Reentry in the Short QT Syndrome With Human-Induced Pluripotent Stem Cell-Derived Cardiac Cell Sheets.
Shinnawi R; Shaheen N; Huber I; Shiti A; Arbel G; Gepstein A; Ballan N; Setter N; Tijsen AJ; Borggrefe M; Gepstein L
J Am Coll Cardiol; 2019 May; 73(18):2310-2324. PubMed ID: 31072576
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional Dysregulation Underlies Both Monogenic Arrhythmia Syndrome and Common Modifiers of Cardiac Repolarization.
Bersell KR; Yang T; Mosley JD; Glazer AM; Hale AT; Kryshtal DO; Kim K; Steimle JD; Brown JD; Salem JE; Campbell CC; Hong CC; Wells QS; Johnson AN; Short L; Blair MA; Behr ER; Petropoulou E; Jamshidi Y; Benson MD; Keyes MJ; Ngo D; Vasan RS; Yang Q; Gerszten RE; Shaffer C; Parikh S; Sheng Q; Kannankeril PJ; Moskowitz IP; York JD; Wang TJ; Knollmann BC; Roden DM
Circulation; 2023 Mar; 147(10):824-840. PubMed ID: 36524479
[TBL] [Abstract][Full Text] [Related]
20. Patient-Specific and Gene-Corrected Induced Pluripotent Stem Cell-Derived Cardiomyocytes Elucidate Single-Cell Phenotype of Short QT Syndrome.
Guo F; Sun Y; Wang X; Wang H; Wang J; Gong T; Chen X; Zhang P; Su L; Fu G; Su J; Yang S; Lai R; Jiang C; Liang P
Circ Res; 2019 Jan; 124(1):66-78. PubMed ID: 30582453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
